Ellington Management Group’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-7,400
| Closed | -$483K | – | 899 |
|
|
2018
Q1 | $483K | Buy |
7,400
+5,067
| +217% | +$331K | 0.03% | 403 |
|
|
2017
Q4 | $170K | Sell |
2,333
-1,845
| -44% | -$134K | 0.03% | 503 |
|
|
2017
Q3 | $383K | Buy |
+4,178
| New | +$383K | 0.07% | 295 |
|
|
2017
Q2 | – | Sell |
-1,022
| Closed | -$222K | – | 933 |
|
|
2017
Q1 | $222K | Buy |
+1,022
| New | +$222K | 0.01% | 540 |
|
|
2016
Q1 | – | Sell |
-912
| Closed | -$299K | – | 733 |
|
|
2015
Q4 | $299K | Buy |
+912
| New | +$299K | 0.11% | 279 |
|
|
2015
Q2 | – | Sell |
-1,233
| Closed | -$607K | – | 921 |
|
|
2015
Q1 | $607K | Buy |
+1,233
| New | +$607K | 0.13% | 224 |
|
|
2014
Q2 | – | Sell |
-1,689
| Closed | -$432K | – | 694 |
|
|
2014
Q1 | $432K | Buy |
+1,689
| New | +$432K | 0.13% | 248 |
|